Kimberly Clark CORP

Market Movers (8-K)

See all →
NASDAQ
Kimberly-Clark announced third quarter 2026 results, highlighting innovation-driven momentum and productivity gains, while also completing its Kenvue transaction and reaffirming its standalone outlook.
NASDAQ
Kimberly-Clark Corporation has completed exchange offers for Kenvue Notes, issuing new Kimberly-Clark Notes and amending the Kenvue Indenture.
Capital raise
NASDAQ
Kimberly-Clark Corporation has finalized its acquisition of Kenvue Inc., creating a leading global consumer health and wellness company with a combined portfolio of 10 billion-dollar brands.
NASDAQ
Kimberly-Clark Corporation has successfully completed a private offering of $4.9 billion in aggregate principal amount of senior unsecured notes to fund its proposed acquisition of Kenvue Inc.
Capital raise
NASDAQ
Kimberly-Clark Corporation has extended the expiration date for its offers to exchange Kenvue Inc. notes for new Kimberly-Clark notes, pushing the deadline to November 2, 2026.
Capital raise
NASDAQ
Kimberly-Clark Corporation has priced a $4.9 billion private offering of senior unsecured notes to fund its proposed acquisition of Kenvue Inc.
Capital raise

Quarterly Earnings (10-Q)

See all →
NASDAQ
Kimberly-Clark's Q3 2026 results show a substantial increase in net income, primarily driven by the divestiture of its International Family Care and Professional segment, alongside strategic acquisitions and ongoing transformation initiatives.
Capital raise
NASDAQ
Kimberly-Clark Corporation announced its second quarter 2026 financial results, highlighting a 0.6% increase in net sales and a significant strategic milestone with the completion of the IFP Transaction.
Capital raise
NASDAQ
Kimberly-Clark Corporation announced its first-quarter 2026 financial results, showcasing a 2.7% increase in net sales driven by organic growth and favorable currency impacts, while also providing updates on its pending acquisition of Kenvue.
Capital raise
NASDAQ
Kimberly-Clark reported a significant decline in Q3 2025 net income and EPS, primarily due to a $130 million tax charge from the One Big Beautiful Bill Act, despite modest organic sales growth.
Worse than expected
NASDAQ
Kimberly-Clark's second quarter 2025 results show a decline in net sales and profitability from continuing operations, impacted by divestitures, currency fluctuations, and cost inflation, while the company progresses with its 2024 Transformation Initiative and the planned International Family Care and Professional (IFP) business joint venture.
Worse than expected
NASDAQ
Kimberly-Clark's Q1 2025 net sales decreased by 6.0% due to unfavorable currency impacts, divestitures, and strategic pricing investments, despite progress in the 2024 Transformation Initiative.
Worse than expected

Annual Reports (10-K)

NASDAQ
Kimberly-Clark's 2025 annual report details a strategic pivot with the Kenvue acquisition and IFP joint venture, alongside a 2.1% net sales decline and a 12.9% drop in operating profit from continuing operations.
Capital raise
Worse than expected
NASDAQ
Kimberly-Clark's 2024 results show a significant increase in operating profit and net income, driven by higher gross margins and the sale of its PPE business, despite a slight decrease in net sales.
Better than expected
NASDAQ
Kimberly-Clark's 2023 annual report details its common stock structure, anti-takeover provisions, and business performance across its personal care, consumer tissue, and K-C professional segments.

Insider Trading (Form 4)

See all →
NASDAQ
Kirk Perry, a Director of Kimberly Clark Corp, received 300 shares of common stock on November 2, 2026.
NASDAQ
Larry J Merlo, a Director of Kimberly Clark Corp, received 300 shares of common stock on November 2, 2026.
NASDAQ
Richard E Allison Jr, a Director of Kimberly Clark Corp, received 300 shares of common stock on November 2, 2026.
NASDAQ
Deirdre Mahlan, a Director of Kimberly Clark Corp, received 39 shares of common stock on November 2, 2026.
NASDAQ
John Culver, a Director of Kimberly Clark Corp, reported multiple transactions in common stock on November 2, 2026.
NASDAQ
Michael D. Hsu, Chairman of the Board and CEO and a Director of Kimberly Clark Corp, received 10 shares of common stock on November 2, 2026.

Proxy Statements (Def-14A)

See all →
NASDAQ
Kimberly-Clark's 2026 proxy statement details a year of strategic portfolio transformation, including major acquisitions and a joint venture, alongside mixed financial results for 2025.
Worse than expected
NASDAQ
Kimberly-Clark Corporation will hold its Annual Meeting of Stockholders virtually on May 1, 2025, to vote on the election of directors, ratification of the auditor, and executive compensation.
NASDAQ
Kimberly-Clark's 2024 results exceeded expectations amidst macroeconomic headwinds, driven by strong execution of the Powering Care strategy.
Better than expected
NASDAQ
Kimberly-Clark Corporation has issued a supplement to its proxy statement clarifying the effect of broker non-votes on Proposal 4, concerning the adoption of an amended and restated certificate of incorporation.
NASDAQ
Kimberly-Clark Corporation will hold its Annual Meeting of Stockholders virtually on May 2, 2024, to vote on the election of directors, ratification of the auditor, executive compensation, and amendments to the certificate of incorporation.
NASDAQ
Kimberly-Clark's proxy statement highlights a successful 2023 with improved organic growth and margins, alongside changes in board leadership and a focus on sustainability and diversity.
Better than expected

Schedule 13G - Passive Investments

See all →
NASDAQ
State Street Corporation has reported beneficial ownership of 6.5% of Kimberly-Clark Corp. common stock as of March 31, 2026.
NASDAQ
Vanguard Capital Management has reported a beneficial ownership of 7.5% in Kimberly-Clark Corp. common stock as of March 31, 2026.
NASDAQ
The Vanguard Group reported zero beneficial ownership in Kimberly-Clark Corp following an internal realignment and disaggregated reporting by its subsidiaries.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, revealing a 12.18% beneficial ownership stake in Kimberly-Clark Corp, totaling over 40 million shares.
NASDAQ
BlackRock, Inc. has filed an Amendment No. 15 to its Schedule 13G, reaffirming its passive 7.6% beneficial ownership in Kimberly-Clark Corporation as of March 31, 2025.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, reporting a 10.53% beneficial ownership stake in Kimberly-Clark Corp as of December 31, 2024.